A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma
Clinical trial NCT04895345 · COMPLETED
Trial details
- NCT number
- NCT04895345
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-15
- Primary completion
- 2024-04-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.